Financial report interval: 2025.12.31 - 2026.03.31
Preview: Eton Pharmaceuticals(ETON) predict that the Revenue is 24.27 M (+40.41%), Beat estimate;the EBIT is 2.414 M (+613.6%), Miss estimate;the EPS is 0.05 (+183.3%), Miss estimate.